5th Gene Therapy Immunogenicity Summit 2024
Hanson Wade
20.08.2024 - 22.08.2024 The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 8:30 AM - 4:00 PM
Kongressthemen
The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.
The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.
Wissenschaftliche Fach-Gesellschaft
Evvnt Promotion / evvnt
Evvnt Promotion / evvnt
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2453359-0?pid=4832
Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, and more
URL:
Brochure: https://go.evvnt.com/2453359-0?pid=4832
Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2453359-2?pid=4832
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
